US equities ยท SEC fundamentals

BRISTOL MYERS SQUIBB CO

BMY ยท CIK 0000014272 ยท Pharmaceutical Preparations

Source: SEC EDGAR/XBRL

Revenue

USD

48.2B USD

Period data
PeriodValue
FY 202146.4B USD
FY 202246.2B USD
FY 202345B USD
FY 202448.3B USD
FY 202548.2B USD

Operating income

USD

No applicable data available

No applicable data available

Net income

USD

7.1B USD

Period data
PeriodValue
FY 20217B USD
FY 20226.3B USD
FY 20238B USD
FY 2024-8.9B USD
FY 20257.1B USD

Total assets

USD

90B USD

Period data
PeriodValue
FY 2021109.3B USD
FY 202296.8B USD
FY 202395.2B USD
FY 202492.6B USD
FY 202590B USD

Equity

USD

18.5B USD

Period data
PeriodValue
FY 202135.9B USD
FY 202231.1B USD
FY 202329.4B USD
FY 202416.3B USD
FY 202518.5B USD

Operating cash flow

USD

14.2B USD

Period data
PeriodValue
FY 202116.2B USD
FY 202213.1B USD
FY 202313.9B USD
FY 202415.2B USD
FY 202514.2B USD

Revenue growth

%

-0.2%

Period data
PeriodValue
FY 20219.1%
FY 2022-0.5%
FY 2023-2.5%
FY 20247.3%
FY 2025-0.2%

Operating income growth

%

No applicable data available

No applicable data available

Net income growth

%

Loss โ†’ Profit

Period data
PeriodValue
FY 2021Loss โ†’ Profit
FY 2022-9.5%
FY 202326.8%
FY 2024Profit โ†’ Loss
FY 2025Loss โ†’ Profit

Operating margin

%

No applicable data available

No applicable data available

Net margin

%

14.6%

Period data
PeriodValue
FY 202115.1%
FY 202213.7%
FY 202317.8%
FY 2024-18.5%
FY 202514.6%

Return on assets

%

7.7%

Period data
PeriodValue
FY 20216.1%
FY 20226.1%
FY 20238.4%
FY 2024-9.5%
FY 20257.7%

Debt/Equity

x

3.87x

Period data
PeriodValue
FY 20212.04x
FY 20222.12x
FY 20232.23x
FY 20244.67x
FY 20253.87x